| Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy T Balatoni, A Mohos, E Papp, T Sebestyén, G Liszkay, J Oláh, A Varga, ... Cancer Immunology, Immunotherapy 67, 141-151, 2018 | 89 | 2018 |
| Altered expression patterns of clock gene mRNAs and clock proteins in human skin tumors Z Lengyel, C Lovig, S Kommedal, R Keszthelyi, G Szekeres, Z Battyáni, ... Tumor Biology 34, 811-819, 2013 | 68 | 2013 |
| Circadian clocks and tumor biology: what is to learn from human skin biopsies? Z Lengyel, Z Battyáni, G Szekeres, V Csernus, AD Nagy General and comparative endocrinology 188, 67-74, 2013 | 16 | 2013 |
| Overpressured thin-layer chromatography and its applications Z Lengyel, E Tyihak, E Mincsovics Journal of Liquid Chromatography 5 (8), 1541-1553, 1982 | 10 | 1982 |
| Florid cutaneous papillomatosis leading to social exclusion B Csete, M Moezzi, ZS Lengyel, B Hodosi, E Zombai, Z Battyani British Journal of Dermatology 153 (3), 667-669, 2005 | 9 | 2005 |
| Cutaneous Cryptococcus albidus infection. A Gyimesi, A Bátor, P Görög, E Telegdy, É Szepes, Á Kappéter, R Gyulai, ... International Journal of Dermatology 56 (4), 2017 | 7 | 2017 |
| Tumor-infiltrating immune cells as potential predictive markers of response to treatment and survival in metastatic melanoma patients receiving ipilimumab T Balatoni, A Moho, T Sebestyen, A Varga, J Olah, Z Lengyel, G Emri, ... JOURNAL OF TRANSLATIONAL MEDICINE 15, 2017 | 3 | 2017 |
| Surgery and staging of melanoma R Gyulai, Z Kádár, Z Lengyel Melanoma-current clinical management and future therapeutics, 2015 | 2 | 2015 |
| ODF Mobile Edition–Towards the development of a mobile office software I Barnaa, P Bauera, K Bernáda, Z Hernáthb, Z Horvátha, B Kőszegia, ... 8 th International Conference on Applied Informatics, 313, 2010 | 2 | 2010 |
| Subtype directed treatment recommendation for rosacea. E Baltás, P Holló, Z Lengyel, A Szegedi, Z Bata-Csörgő | 1 | 2015 |
| Low dose interferon alpha therapy induced autoimmunity in malignant melanoma. Z Battyáni, Z Lengyel, Z Kutasi, L Zilahi, T Berki | 1 | 2010 |
| Gyógyítható lesz-e a melanoma? Perspektívák a melanoma kezelésében= Will melanoma be curable? Perspectives in melanoma therapy Z Lengyel, E Baltás, R Gyulai Bőrgyógyászati és Venerológiai Szemle 93 (4), 179-184, 2017 | | 2017 |
| Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts V Hirsh, S Pignata, M Bersanelli, L Gnetti, C Azzoni, L Bottarelli, ... Journal of Translational Medicine 15, 1-14, 2017 | | 2017 |
| Successful treatment of locally advanced Merkel cell carcinoma with somatostatin analogue-lanreotide Z Lengyel, Z Horvath, R Gyulai MELANOMA RESEARCH 26, E109-E109, 2016 | | 2016 |
| Significance of CT scans in melanoma surveillance-10 year retrospective, single center experience Z Lengyel, M Pozsgai, K Nemeth, R Gyulai MELANOMA RESEARCH 26, E50-E51, 2016 | | 2016 |
| Epidemiological, Clinicopathological and Virological Features of Merkel Cell Carcinomas in Medical Center of University of Pécs, Hungary (2007–2012) KB Horváth, P Pankovics, E Kálmán, Z Kádár, Z Battyáni, Z Lengyel, ... Pathology & Oncology Research 22, 71-77, 2016 | | 2016 |
| Expression patterns of clock and clock controlled gene mRNAs in psoriatic skin lesions Z Lengyel, A Kinyo, S Horvath, A Nagy, R Gyulai JOURNAL OF INVESTIGATIVE DERMATOLOGY 135, S68-S68, 2015 | | 2015 |
| A Client-Server Model for Editing ODF Documents on Mobile Devices Z Horváth, I Barna, P Bauer, K Bernád, Z Hernáth, B Koszegi, G Kovács, ... Acta Electrotechnica et Informatica 11 (3), 17, 2011 | | 2011 |
| P054. A case of blastic plasmocytoid dendritic cell neoplasm Z Lengyel, B Kajtár, A Nagy, Z Battyáni Melanoma Research 21, e45-e46, 2011 | | 2011 |
| POLY (ADENOSINE DIPHOSPHATE-RIBOSE) POLYMERASE-1 EXPRESSION IN CUTENEOUS MALIGNANT MELANOMAS AS A NEW MOLECULAR MARKER OF AGGRESSIVE TUMOR B Csete, Z Lengyel, Z Kadar, Z Battyani ANTICANCER RESEARCH 28 (5 C), 3248-3249, 2008 | | 2008 |
